CMSC Monday, May 12 2008
CMSC Online



 
Home arrow CMSC Online arrow For MS Professionals arrow Presentations
CHAMPIONS and BENEFIT Investigators Discuss Their Studies Print E-mail
Recent Clinical Trials: CHAMPIONS and BENEFIT Investigators Discuss Their Studies
Sponsored by the Postgraduate Institute for Medicine
Release date: April 2007

Expiration date: April 2008
Estimated time to complete activity: 1 hour

This educational program is supported through an educational grant from Biogen IDEC and Elan Pharmaceuticals Inc.

Program Overview
MS is often heralded by a single demyelinating event known as clinically isolated syndrome. Patients who present with CIS along with evidence of subclinical disease activity on MRI are at a higher risk of developing clinically definite MS than patients who have normal results on MRI. Early treatment with beta interferon has become a standard of care for these patients. This program will discuss the three interferon therapies approved for MS and the clinical trials that support their use following a single demyelinating event.

Technical Requirements
Processor Speed: 1.4 GHz P3
Memory: 256 MB RAM (20 MB Available)
Operating Systems Supported: Windows 2000 / XP
Browsers Supported: Internet Explorer 5.5 or greater and Mozilla Firefox
Additional Requirements: Flash player 8.0 or greater 800x600 Resolution or Higher with 32-bit color
Connection Speed: 128 Kbps or better
Adobe Reader 6.0 or greater.

CME Information
Click here to review the complete CME information.